abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to obtaining a polymeric protein structure capable of selective interaction with organic targets and can be used in medicine. The polymer protein structure contains a recombinant fusion protein, as a recurring structural element, which includes parts B, REP and CT. n EFFECT: invention allows for producing a protein structure, which can be used as an affine medium and scaffold material for cells. n 41 cl, 34 dwg, 5 tbl, 28 ex |